Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-02-24
1995-11-07
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514397, A61K 31495, A61K 31415
Patent
active
054648351
ABSTRACT:
A novel use for the class of biologically active bis-heterocyclic, e.g., bis-indole alkaloid compounds, which have been named topsentins, nortopsentins, hamacanthins, or dragmacidins, pharmaceutical compositions containing them, methods of producing the compounds, and methods of using the compounds are disclosed. Specifically, the novel utility pertains to the anti-inflammatory properties exhibited by the bis-indole compounds and their analogs.
REFERENCES:
patent: 4866084 (1989-09-01), Gunasekera et al.
patent: 4895844 (1990-01-01), Komoto et al.
patent: 4970226 (1990-11-01), Sun et al.
Faulkner, D. J. (1984) "Marine Natural Products: Metabolites of Marine Invertebrates" Natural Products Reports 1:551-598.
Faulkner, D. J. (1986) "Marine Natural Products" Natural Products Reports 3:1-33.
Faulkner, D. J. (1987) "Marine Natural Products" Natural Products Reports 4(5):539-576.
Uemura, D. et al. (1985) "Norhalichondrin A: An Antitumor Polyether Macrolide from a Marine Sponge" J. Am. Chem. Soc. 107:4796-4798.
Moquin, C., M. Guyot (1984) "Grossularine, A Novel Indole Derivative from the Marine Tunicate, Dendrodoa grossularia" Tetrahedron Letters 25(44):5047-5048.
Norton, R. S., R. J. Wells (1982), "A Series of Chiral Polybrominated Biindoles from the Marine Blue-Green Alga Rivularia firma. Application of .sup.13 C NMR Spin-Latice Relaxation Data and .sup.13 C-.sup.1 H Coupling Constants to Structure Elucidation" J. Am. Chem. Soc. 104(13):3628-3635.
Nixon, J. S. et al. (1991) "Novel Potent and Selective Inhibitors of Protein Kinase C Show Oral Anti-Inflammatory Activity" Drugs Exptl. Clin. Res. 17(8):389-393.
Bit, R. A. et al. (1993) "Inhibitors of Protein Kinase C. 3. Potent and Highly Selective Bisindolylmaleimides by Conformational Restriction" J. Med. Chem. 36:21-29.
Muid, R. E. et al. (1991) "A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuli" FEBS Letters 293(1,2):169-172.
Gunasekera Sarath P.
Jacobs Robert
McConnell Oliver J.
Saucy Gabriel
Harbor Branch Oceanographic Institution Inc.
Tsang Cecilia
University of California
LandOfFree
Use for bis-heterocyclic compounds and pharmaceutical compositio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use for bis-heterocyclic compounds and pharmaceutical compositio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use for bis-heterocyclic compounds and pharmaceutical compositio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-197407